← Leaderboards
Amy G Hise
Louis Stokes Cleveland Va Medical Center
$3,239,097
Attributed
$3,239,097
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $855.3K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,239,097 · 4
VA$0 · 2
By mechanism
R01$1,737,377 · 1
R21$909,070 · 2
K08$592,650 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsPathway InteractionsImmune ResponseInfectionImmunePathogenOral Mucous Membrane StructureMediatingIn VitroCytokineResponseHost DefensePattern Recognition ReceptorMolecularImmunologic ReceptorsInflammatory ResponseAdultCandidaInflammatoryEpithelial CellsMouse ModelOralCandida AlbicansDectin 1
Grant awards (25)
Host factors affecting susceptibility to Candida auris.$0
I01 · FY2024 · VA · contact PI
Host factors affecting susceptibility to Candida auris.$0
I01 · FY2023 · VA · contact PI
Host factors affecting susceptibility to Candida auris.$0
I01 · FY2022 · VA · contact PI
Host factors affecting susceptibility to Candida auris.$0
I01 · FY2021 · VA · contact PI
Role of inflammasomes in mucosal and systemic candidiasis.$0
I01 · FY2018 · VA · contact PI
Role of inflammasomes in mucosal and systemic candidiasis.$0
I01 · FY2017 · VA · contact PI
Role of inflammasomes in mucosal and systemic candidiasis.$0
I01 · FY2016 · VA · contact PI
Role of inflammasomes in mucosal and systemic candidiasis.$0
I01 · FY2015 · VA · contact PI
Host Defense in Oral Candidiasis$334,420
R01 · FY2011 · DE · contact PI
Host Defense in Oral Candidiasis$344,634
R01 · FY2010 · DE · contact PI
Innate Immune Sensing of Rift Valley Fever Virus$198,538
R21 · FY2010 · AI · contact PI
Mucosal innate immune defense to Rift Valley fever virus$189,197
R21 · FY2010 · AI · contact PI
Innate Immune Sensing of Rift Valley Fever Virus$15,700
R21 · FY2010 · AI · contact PI
Mucosal innate immune defense to Rift Valley fever virus$14,004
R21 · FY2010 · AI · contact PI
Host Defense in Oral Candidiasis$347,992
R01 · FY2009 · DE · contact PI
Innate Immune Sensing of Rift Valley Fever Virus$248,423
R21 · FY2009 · AI · contact PI
Mucosal innate immune defense to Rift Valley fever virus$243,208
R21 · FY2009 · AI · contact PI
Host Defense in Oral Candidiasis$15,700
R01 · FY2009 · DE · contact PI
Host Defense in Oral Candidiasis$343,503
R01 · FY2008 · DE · contact PI
Host Defense in Oral Candidiasis$351,128
R01 · FY2007 · DE · contact PI
Innate immune responses in lymphatic filariasis$122,850
K08 · FY2007 · AI · contact PI
Innate immune responses in lymphatic filariasis$122,850
K08 · FY2006 · AI · contact PI
Innate immune responses in lymphatic filariasis$122,850
K08 · FY2005 · AI
Innate immune responses in lymphatic filariasis$112,050
K08 · FY2004 · AI
Innate immune responses in lymphatic filariasis$112,050
K08 · FY2003 · AI